Standout Papers

PI3K Inhibitors in Cancer: Clinical Implications and Adverse Effects 2021 2026 2022 2024184
  1. PI3K Inhibitors in Cancer: Clinical Implications and Adverse Effects (2021)
    Rosalin Mishra, Hima Patel et al. International Journal of Molecular Sciences

Immediate Impact

59 standout
Sub-graph 1 of 23

Citing Papers

Emerging Delivery Systems for Enabling Precision Nucleic Acid Therapeutics
2025 Standout
Glioblastoma: Clinical Presentation, Multidisciplinary Management, and Long-Term Outcomes
2025 Standout
1 intermediate paper

Works of Rosalin Mishra being referenced

PI3K Inhibitors in Cancer: Clinical Implications and Adverse Effects
2021 Standout
HER3 signaling and targeted therapy in cancer
2018

Author Peers

Author Last Decade Papers Cites
Rosalin Mishra 334 404 128 136 19 698
Hima Patel 267 367 82 122 19 652
Julia Kirshner 373 364 164 75 29 835
Raul Ayala 352 476 84 248 17 816
Lisa Malburg 405 488 75 179 14 770
Young‐Kwang Yoon 436 407 86 201 22 722
D. Gandara 370 474 41 199 26 821
B. Markman 293 465 64 151 19 681
Kenneth E. Hook 338 415 107 109 15 782
Grit S. Herter-Sprie 302 342 46 102 14 659
Monica Red Brewer 382 351 197 219 12 615

All Works

Loading papers...

Rankless by CCL
2026